
### [MONDO:0016134](http://purl.obolibrary.org/obo/MONDO_0016134)
**Label:** rare hereditary systemic disease with peripheral neuropathy

**Subclasses:** [MONDO:0008783](http://purl.obolibrary.org/obo/MONDO_0008783) (Tangier disease), [MONDO:0019441](http://purl.obolibrary.org/obo/MONDO_0019441) (ATTRV122I amyloidosis), [MONDO:0007100](http://purl.obolibrary.org/obo/MONDO_0007100) (familial amyloid neuropathy), [MONDO:0007097](http://purl.obolibrary.org/obo/MONDO_0007097) (Finnish type amyloidosis), 

**Corr. equiv. classes:** [Orphanet:85451](http://www.orpha.net/ORDO/Orphanet_85451), [OMIM:205400](http://purl.obolibrary.org/obo/OMIM_205400), [Orphanet:85447](http://www.orpha.net/ORDO/Orphanet_85447), [Orphanet:85448](http://www.orpha.net/ORDO/Orphanet_85448), [OMIM:105120](http://purl.obolibrary.org/obo/OMIM_105120), [Orphanet:31150](http://www.orpha.net/ORDO/Orphanet_31150), [OMIM:105210](http://purl.obolibrary.org/obo/OMIM_105210), 

**Class expressions from DL-Learner:**

- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0011004](http://purl.obolibrary.org/obo/HP_0011004) (Abnormal systemic arterial morphology) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0008404](http://purl.obolibrary.org/obo/HP_0008404) (Nail dystrophy) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0006704](http://purl.obolibrary.org/obo/HP_0006704) (Abnormal coronary artery morphology) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0003119](http://purl.obolibrary.org/obo/HP_0003119) (Abnormality of lipid metabolism) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0003107](http://purl.obolibrary.org/obo/HP_0003107) (Abnormality of cholesterol metabolism) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0002634](http://purl.obolibrary.org/obo/HP_0002634) (Arteriosclerosis) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0002621](http://purl.obolibrary.org/obo/HP_0002621) (Atherosclerosis) 64.29%
- [HP:0001349](http://purl.obolibrary.org/obo/HP_0001349) (Facial diplegia) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 64.29%


